Advanced Search
Submit Manuscript Volume 30, No 9, Sep 2020
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 30 Issue 9, September 2020: 717-731 |
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals
Yanan Cao1,2,† , Lin Li1,2,† , Min Xu1,† , Zhimin Feng1,† , Xiaohui Sun1,† , Jieli Lu1,† , Yu Xu1,† , Peina Du1,† , Tiange Wang1,† , Ruying Hu3 , Zhen Ye3 , Lixin Shi4 , Xulei Tang5 , Li Yan6 , Zhengnan Gao7 , Gang Chen8 , Yinfei Zhang9 , Lulu Chen10 , Guang Ning1,* , Yufang Bi1,* , Weiqing Wang1,* , The ChinaMAP Consortium
1National Clinical Research Centre for Metabolic Diseases, State Key Laboratory of Medical Genomics, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;Metabolic diseases are the most common and rapidly growing health issues worldwide. The massive population-based human genetics is crucial for the precise prevention and intervention of metabolic disorders. The China Metabolic Analytics Project (ChinaMAP) is based on cohort studies across diverse regions and ethnic groups with metabolic phenotypic data in China. Here, we describe the centralized analysis of the deep whole genome sequencing data and the genetic bases of metabolic traits in 10,588 individuals from the ChinaMAP. The frequency spectrum of variants, population structure, pathogenic variants and novel genomic characteristics were analyzed. The individual genetic evaluations of Mendelian diseases, nutrition and drug metabolism, and traits of blood glucose and BMI were integrated. Our study establishes a large-scale and deep resource for the genetics of East Asians and provides opportunities for novel genetic discoveries of metabolic characteristics and disorders.
https://doi.org/10.1038/s41422-020-0322-9